TONGRENTANGCARE (02667) commenced trading on its first day of listing. The company's final offer price was set at HK$5.5 per share, with a total of 108 million shares issued. Each board lot consists of 500 shares. The net proceeds from the offering are approximately HK$532 million.
As of the latest update, the stock is down 13.45%, trading at HK$4.76, with a turnover of HK$45.2521 million.
TONGRENTANGCARE is a strategic Traditional Chinese Medicine (TCM) healthcare services group under the Beijing Tong Ren Tang Co.,Ltd. umbrella. The company provides comprehensive TCM medical services to individual clients, standardized management services to institutional clients, and a variety of pharmaceutical and other related products.
The company integrates medical treatment with wellness, offering modern and customized TCM healthcare services. It combines TCM pharmacological treatments with non-pharmacological therapies, delivering standardized management and tailored treatment plans to meet diverse client needs.
According to a Frost & Sullivan report, based on projected total outpatient and inpatient visits for 2025, TONGRENTANGCARE is the largest TCM hospital group in China's non-public TCM hospital services sector, holding a 1.5% market share. During the same period, based on total revenue, the company ranks second in the non-public TCM hospital services industry with a 0.2% market share. The market size of this sector accounts for 54.9% of the overall Chinese TCM healthcare services market in the same year.
Comments